TLR2 and Alzheimer disease: In mild cognitive impairment and very early-stage Alzheimer disease patients, monocytes have been suggested to be the sources of increased oxidation products, exhibiting significantly increased chemotaxis and cytokine production in response to Toll-like receptor 2 and 4 stimulation.